Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sina Pishgam Novin is a leading Iranian pharmaceutical company specializing in the development, manufacturing, and distribution of high-tech medicinal products. The company focuses on critical therapeutic areas such as oncology, neurology, and endocrinology, providing essential treatments to the Iranian healthcare market. Operating from a modern manufacturing facility in the Eshtehard Industrial Town, Sina Pishgam Novin produces a diverse portfolio of generic and biosimilar medications. In addition to its manufacturing capabilities, the firm serves as a strategic partner for international pharmaceutical companies seeking to enter the regional market. The company is committed to maintaining international quality standards, including Good Manufacturing Practice (GMP) certifications. Through its robust distribution network, Sina Pishgam Novin ensures the availability of specialized therapies for patients with chronic and life-threatening conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sina Pishgam Novin Daroo.